Close Menu

antibodies

Industry Briefs: Feb 5, 2009

Premium

Thermo Fisher Scientific, Agilent, NHLBI, Journal of Proteome Research, Roche, Fluorotechnics, and more.

Without specific guidance from the FDA regarding KRAS testing, drugmakers Bristol-Myers Squibb and Amgen are facing lower sales of their colorectal cancer drugs Erbitux and Vectibix, and may need to get creative in how they market their drugs to patients and doctors.

New Product Watch: Feb 3, 2009

Premium

Navigenics, ImaGenes, Ocimum Biosolutions

Proteins, Front and Center

Premium

Once a tool that only piqued the interest of technology developers, protein microarrays have come into their own as scientists find new ways to apply them in basic and translational studies.

The Realm of Noncoding RNAs

Premium

Small (and not-so-small) noncoding RNAs have thrown a spanner in the works of understanding genome function. We take a look at the major questions brought about by micro-RNA, Piwi-interacting RNA, and more.

A Whole New System

Premium

Now in its ninth year, the experiment that was the Institute for Systems Biology has become an established research organization known for its focus on translational science.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.